BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 24754158)

  • 1. [Specificity of traditional Chinese medicine's clinical re-evaluation].
    Li LD; Li YK; Li FJ
    Zhongguo Zhong Yao Za Zhi; 2014 Jan; 39(1):3-4. PubMed ID: 24754158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of re-evaluation and development of Chinese herbal drugs].
    Gao Y; Ma Z; Zhang B
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):1-4. PubMed ID: 22741451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Some issues to notice in the research and quality evaluation of external preparations of traditional Chinese medicine].
    Jin F
    Zhongguo Zhong Yao Za Zhi; 2010 Nov; 35(21):2934-6. PubMed ID: 21322963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of traditional Chinese medicine reference standards in quality control of Chinese herbal pieces].
    Lu TL; Li JC; Yu JY; Cai BC; Mao CQ; Yin FZ
    Zhongguo Zhong Yao Za Zhi; 2014 Jan; 39(1):149-52. PubMed ID: 24754185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis and thinking on status of quality standard of ethnic medicine].
    Yang Y; Zhang Y; Huang Y; Lai XR; Fan G; You JL
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(17):2878-81. PubMed ID: 24380315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [New idea of traditional Chinese medicine quality control based on "composition structure" theory].
    Liu D; Jia X; Yu D
    Zhongguo Zhong Yao Za Zhi; 2012 Mar; 37(6):865-70. PubMed ID: 22715740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Postmarketing herbs clinical evaluation should concern about re-evaluating symptoms].
    He W; Xie Y; Wang Y
    Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1498-500. PubMed ID: 20822030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of quality traceability system of traditional Chinese medicine].
    Cai Y; Hu H; Ni JY; Wang YT
    Zhongguo Zhong Yao Za Zhi; 2013 Nov; 38(22):3829-33. PubMed ID: 24558859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Problems in quality standard research of new traditional Chinese medicine compound].
    Zhou G; He YP
    Zhongguo Zhong Yao Za Zhi; 2014 Sep; 39(17):3389-91. PubMed ID: 25522635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modernization of traditional Chinese medicine.
    Guo DA; Lu A; Liu L
    J Ethnopharmacol; 2012 Jun; 141(2):547-8. PubMed ID: 22569212
    [No Abstract]   [Full Text] [Related]  

  • 11. [Standardization of names in prescriptions of traditional Chinese medicines].
    Li CF; Zhang YJ; Fan DH; Zhang MJ; Bai X; Yang WH; Qi SY; Zhang ZJ; Xue CM; Mao LY; Cao JL
    Zhongguo Zhong Yao Za Zhi; 2017 Jan; 42(1):198-202. PubMed ID: 28945049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advance in hepatic protective formulations of traditional Chinese medicine and their quality control methods].
    Ju LN; Tong SS; Wang L; Yu JN; Xu XM
    Zhongguo Zhong Yao Za Zhi; 2012 Oct; 37(20):3007-11. PubMed ID: 23311143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishing quality assurance system of processed Chinese medicine to ensure clinical effect of traditional Chinese medicine].
    Xiao Y; Zhang C; Li L; Jiang Y; Xu D; Gu Z; Wang Y
    Zhongguo Zhong Yao Za Zhi; 2012 Jul; 37(14):2178-80. PubMed ID: 23126210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Problems in medicinal materials research of new traditional Chinese medicine].
    Zhou G; Wang T; He YP
    Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(16):3192-5. PubMed ID: 25509314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical orientation of post-marketing Chinese patent drugs: an evidence-based practice].
    Shang HC; Zhang BL; Li YP
    Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):887-90. PubMed ID: 18782528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems in preparation of toxic herbs in process of research and development of new traditional Chinese medicine of rheumatism, orthopedics and surgery].
    Wang T; Zhou G
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(17):2653-5. PubMed ID: 23236771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Discussion on role of enterprises in re-evaluation of traditional Chinese medicine injection].
    Li X; Song L; Liu Y; Bo Y
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1326-8. PubMed ID: 19673401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asian medicine. The new face of traditional Chinese medicine.
    Normile D
    Science; 2003 Jan; 299(5604):188-90. PubMed ID: 12522228
    [No Abstract]   [Full Text] [Related]  

  • 19. [Design requirements for clinical trials on re-evaluation of safety and efficacy of post-marketed Chinese herbs].
    Xie Y; Wei X
    Zhongguo Zhong Yao Za Zhi; 2011 Oct; 36(20):2768-70. PubMed ID: 22292360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Innovation and practice of component structure theory on material basis of traditional Chinese medicine prescriptions].
    Feng L; Zhang MH; Gu JF; Wu C; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2013 Nov; 38(21):3603-7. PubMed ID: 24494539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.